Catalyst Wire Dossier Catalyst Wire Dossier

TRYNGOLZA

olesarsen sodium · Ionis Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TRYNGOLZA, covering 2024-12-19 to 2025-12-03. Get the full timeline:

Most recent: EMA Authorised: Tryngolza (olezarsen sodium) — Swedish Orphan Biovitrum AB (publ)

See pricing